However, another study has reported that ALK positivity might indicate a good prognosis (6), while patients with gene rearrangements involving both RAN binding protein 2 (RanBP2) and ALK exhibit a higher tumor recurrence rate and a relatively poor prognosis (14). This evidence concerns the gene RANBP2 and neoplasm.